Generic drug authorization within the WTO

This procedure concerns a resolution regarding the authorization and accessibility of generic medicines within the framework of World Trade Organization (WTO) agreements. It addresses the balance between protecting intellectual property rights and ensuring that essential medicines remain affordable and available globally.

This affects the pharmaceutical industry and global health organizations. It primarily impacts developing countries seeking to produce or import lower-cost generic versions of patented drugs to improve public health outcomes.